TP53/p53 alterations in thyroid cancer: Dedifferentiation, radioiodine refractoriness and risk stratification.
- DOI
- 10.1016/j.critrevonc.2026.105601
- Published
- 2026 Sep 19
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105601,
title = {TP53/p53 alterations in thyroid cancer: Dedifferentiation, radioiodine refractoriness and risk stratification.},
author = {Shi Y and Huang J and Dong W and Lv C and Guan Y and Liu P and Zhao G and Li Z and Zhang P and Zhang H},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105601},
url = {https://doi.org/10.1016/j.critrevonc.2026.105601}
}RIS
TY - JOUR TI - TP53/p53 alterations in thyroid cancer: Dedifferentiation, radioiodine refractoriness and risk stratification. AU - Shi Y AU - Huang J AU - Dong W AU - Lv C AU - Guan Y AU - Liu P AU - Zhao G AU - Li Z AU - Zhang P AU - Zhang H PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105601 UR - https://doi.org/10.1016/j.critrevonc.2026.105601 ER -
APA
Y, S., J, H., W, D., C, L., Y, G., P, L., G, Z., Z, L., P, Z., & H, Z. (2026). TP53/p53 alterations in thyroid cancer: Dedifferentiation, radioiodine refractoriness and risk stratification.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105601
Source records
- pubmed · retrieved 2026-09-26T04:25:23.779Z